WP
ELV icon

WMS Partners’s Elevance Health ELV Stock Holding History

WMS Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-460
Closed -$239K – 304
2024
Q3 		$239K Sell
460
-252
-35% -$135K 0.01% 253
2024
Q2 		$386K Buy
712
+1
+0.1% +$529 0.02% 181
2024
Q1 		$369K Buy
711
+31
+5% +$15.4K 0.03% 198
2023
Q4 		$321K Sell
680
-510
-43% -$236K 0.02% 204
2023
Q3 		$518K Sell
1,190
-2
-0.2% -$907 0.04% 150
2023
Q2 		$530K Buy
1,192
+728
+157% +$336K 0.04% 155
2023
Q1 		$213K Sell
464
-13
-3% -$6.19K 0.02% 252
2022
Q4 		$244K Buy
477
+1
+0.2% +$508 0.02% 227
2022
Q3 		$216K Buy
476
+13
+3% +$6.22K 0.03% 222
2022
Q2 		$223K Hold
463
– – 0.03% 215
2022
Q1 		$227K Buy
+463
New +$212K 0.03% 226
2021
Q1 		– Sell
-966
Closed -$310K – 239
2020
Q4 		$310K Buy
966
+12
+1% +$3.68K 0.05% 181
2020
Q3 		$256K Buy
+954
New +$257K 0.05% 192

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

WMS Partners's ELV Position: Q4 2024 in Review

WMS Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 460 shares — an estimated $239K sold.

WMS Partners first reported a position in ELV in Q3 2020 and held it in 13 quarters. The position peaked at $530K in Q2 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • WMS Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • WMS Partners sold 460 Elevance Health shares in Q4 2024, an estimated $239K.
  • WMS Partners first reported a position in Elevance Health in Q3 2020 and held it in 13 quarters.
  • WMS Partners's Elevance Health position peaked at $530K in Q2 2023.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on WMS Partners's 13F filing for Q4 2024, filed 14 Feb 2025.